A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis
Clinical trial NCT01732211 · TERMINATED
Trial details
- NCT number
- NCT01732211
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-15
- Primary completion
- 2013-09-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.